Published in Vet Res on June 13, 2014
A synthetic biology approach for a vaccine platform against known and newly emerging serotypes of bluetongue virus. J Virol (2014) 0.84
Virus replicon particles expressing porcine reproductive and respiratory syndrome virus proteins elicit immune priming but do not confer protection from viremia in pigs. Vet Res (2016) 0.78
Development of a helper cell-dependent form of peste des petits ruminants virus: a system for making biosafe antigen. Vet Res (2015) 0.77
Protective Efficacy in Sheep of Adenovirus-Vectored Vaccines against Bluetongue Virus Is Associated with Specific T Cell Responses. PLoS One (2015) 0.75
Attenuated vesicular stomatitis viruses as vaccine vectors. J Virol (1999) 3.04
Assignment of the genome segments of bluetongue virus type 1 to the proteins which they encode. Virology (1984) 2.60
Vesicular stomatitis virus: re-inventing the bullet. Trends Mol Med (2004) 2.42
Bluetongue in Europe: past, present and future. Philos Trans R Soc Lond B Biol Sci (2009) 2.15
Detection of a fourth orbivirus non-structural protein. PLoS One (2011) 2.11
Bluetongue virus: virology, pathogenesis and immunity. Vet Res (2008) 1.98
Re-emergence of bluetongue, African horse sickness, and other orbivirus diseases. Vet Res (2010) 1.81
Physicochemical and morphological relationships of some arthropod-borne viruses to bluetongue virus--a new taxonomic group. Physiocochemical and serological studies. J Gen Virol (1971) 1.78
Evaluation of the humoral immune response in adult dairy cattle three years after vaccination with a bluetongue serotype 8 inactivated vaccine. Vaccine (2011) 1.65
Physicochemical and morphological relationships of some arthropod-borne viruses to bluetongue virus--a new taxonomic group. Electron microscopic studies. J Gen Virol (1971) 1.56
Isolation of a capsid protein of bluetongue virus that induces a protective immune response in sheep. Virology (1987) 1.43
Expression and functional characterization of bluetongue virus VP2 protein: role in cell entry. J Virol (1999) 1.29
Bluetongue virus coat protein VP2 contains sialic acid-binding domains, and VP5 resembles enveloped virus fusion proteins. Proc Natl Acad Sci U S A (2010) 1.22
Vaccines against bluetongue in Europe. Comp Immunol Microbiol Infect Dis (2007) 1.17
Rapid detection and quantitation of Bluetongue virus (BTV) using a Molecular Beacon fluorescent probe assay. J Virol Methods (2006) 1.16
Use of influenza C virus glycoprotein HEF for generation of vesicular stomatitis virus pseudotypes. J Gen Virol (2005) 1.08
Structure of the bluetongue virus genome and its encoded proteins. Curr Top Microbiol Immunol (1990) 1.08
A vesicular stomatitis virus replicon-based bioassay for the rapid and sensitive determination of multi-species type I interferon. PLoS One (2011) 1.07
Vesicular stomatitis virus-based H5N1 avian influenza vaccines induce potent cross-clade neutralizing antibodies in rhesus macaques. J Virol (2011) 1.05
Impact of bluetongue virus infection on the international movement and trade of ruminants. J Am Vet Med Assoc (2006) 1.01
Fusion-active glycoprotein G mediates the cytotoxicity of vesicular stomatitis virus M mutants lacking host shut-off activity. J Gen Virol (2010) 1.01
Bluetongue vaccination in Europe. Expert Rev Vaccines (2010) 0.99
In vivo and in vitro propagation and transmission of Toggenburg orbivirus. Res Vet Sci (2011) 0.98
Generation of replication-defective virus-based vaccines that confer full protection in sheep against virulent bluetongue virus challenge. J Virol (2011) 0.97
Recombinant canarypox virus vaccine co-expressing genes encoding the VP2 and VP5 outer capsid proteins of bluetongue virus induces high level protection in sheep. Vaccine (2006) 0.97
Changes in the outer capsid proteins of bluetongue virus serotype ten that abrogate neutralization by monoclonal antibodies. Virus Res (2000) 0.97
The impact of naturally-occurring, trans-placental bluetongue virus serotype-8 infection on reproductive performance in sheep. Vet J (2010) 0.96
A recombinant vesicular stomatitis virus replicon vaccine protects chickens from highly pathogenic avian influenza virus (H7N1). Vaccine (2009) 0.94
Bluetongue virus replication, molecular and structural biology. Vet Ital (2010) 0.94
Understanding and altering cell tropism of vesicular stomatitis virus. Virus Res (2013) 0.91
An equine herpesvirus type 1 (EHV-1) expressing VP2 and VP5 of serotype 8 bluetongue virus (BTV-8) induces protection in a murine infection model. PLoS One (2012) 0.90
Antibody responses and protective immunity to recombinant vaccinia virus-expressed bluetongue virus antigens. Vet Immunol Immunopathol (1997) 0.87
Protection of IFNAR (-/-) mice against bluetongue virus serotype 8, by heterologous (DNA/rMVA) and homologous (rMVA/rMVA) vaccination, expressing outer-capsid protein VP2. PLoS One (2013) 0.85
Vaccination with recombinant RNA replicon particles protects chickens from H5N1 highly pathogenic avian influenza virus. PLoS One (2013) 0.85
Virological and pathological findings in Bluetongue virus serotype 8 infected sheep. Vet Microbiol (2010) 0.85
Rapid generation of replication-deficient monovalent and multivalent vaccines for bluetongue virus: protection against virulent virus challenge in cattle and sheep. J Virol (2013) 0.84
Epizootic congenital hydranencephaly and abortion in cattle due to bluetongue virus serotype 8 in the Netherlands. Tijdschr Diergeneeskd (2009) 0.84
Vertical transmission of bluetongue virus serotype 8 virus in Dutch dairy herds in 2007. Vet Microbiol (2009) 0.82
Possible adverse reactions in sheep after vaccination with inactivated BTV vaccines. Vet Rec (2010) 0.80
Recombinant vaccines against bluetongue virus. Virus Res (2013) 0.79
Myxomavirus as a vector for the immunisation of sheep: protection study against challenge with bluetongue virus. Vaccine (2012) 0.79
Regional seroprevalence of bluetongue virus in cattle in Illinois and western Indiana. Am J Vet Res (2007) 0.79
Detection of neutralizing antibodies against Bluetongue virus serotype 8 by an optimized plasma neutralization test. J Virol Methods (2012) 0.78
Abortions, stillbirths and deformities in sheep at the Al-Ahsa oasis in eastern Saudi Arabia: isolation of a bluetongue serogroup virus from the affected lambs. Rev Sci Tech (2004) 0.77
[Bluetongue disease in Swiss sheep breeds: clinical signs after experimental infection with bluetongue virus serotype 8]. Schweiz Arch Tierheilkd (2008) 0.77
Evaluation of the humoral immune responses in adult cattle and sheep, 4 and 2.5 years post-vaccination with a bluetongue serotype 8 inactivated vaccine. Vaccine (2013) 0.76
Selective attention to philopatric models causes directed social learning in wild vervet monkeys. Proc Biol Sci (2010) 1.45
Classical swine fever virus interferes with cellular antiviral defense: evidence for a novel function of N(pro). J Virol (2003) 1.42
Classical swine fever virus Npro interacts with interferon regulatory factor 3 and induces its proteasomal degradation. J Virol (2007) 1.34
N(pro) of classical swine fever virus is an antagonist of double-stranded RNA-mediated apoptosis and IFN-alpha/beta induction. Virology (2005) 1.13
Classical swine fever virus can remain virulent after specific elimination of the interferon regulatory factor 3-degrading function of Npro. J Virol (2008) 1.01
Nonstructural proteins NS2-3 and NS4A of classical swine fever virus: essential features for infectious particle formation. Virology (2007) 1.00
In vivo and in vitro propagation and transmission of Toggenburg orbivirus. Res Vet Sci (2011) 0.98
Attenuation of classical swine fever virus by deletion of the viral N(pro) gene. Vaccine (2004) 0.93
Antigenic characterization of recombinant hemagglutinin proteins derived from different avian influenza virus subtypes. PLoS One (2010) 0.90
Two newly developed E(rns)-based ELISAs allow the differentiation of Classical Swine Fever virus-infected from marker-vaccinated animals and the discrimination of pestivirus antibodies. Vet Microbiol (2012) 0.89
Nucleocapsid protein-based enzyme-linked immunosorbent assay for detection and differentiation of antibodies against European and North American porcine reproductive and respiratory syndrome virus. Clin Diagn Lab Immunol (2002) 0.89
Establishment and characterisation of two cDNA-derived strains of classical swine fever virus, one highly virulent and one avirulent. Virus Res (2003) 0.85
Virological and pathological findings in Bluetongue virus serotype 8 infected sheep. Vet Microbiol (2010) 0.85
Development and validation of a multiplex, real-time RT PCR assay for the simultaneous detection of classical and African swine fever viruses. PLoS One (2013) 0.84
Classical swine fever virus replicon particles lacking the Erns gene: a potential marker vaccine for intradermal application. Vet Res (2006) 0.81
Epidemiology of avian influenza virus in wild birds in Switzerland between 2006 and 2009. Avian Dis (2010) 0.80
Chimeric pestiviruses: candidates for live-attenuated classical swine fever marker vaccines. J Gen Virol (2007) 0.78
Long-term infection of goats with bluetongue virus serotype 25. Vet Microbiol (2013) 0.77
New insights into the antigenic structure of the glycoprotein E(rns) of classical swine fever virus by epitope mapping. Virology (2012) 0.76
Establishment and application of bicistronic classical swine fever virus genomes for foreign gene expression and complementation of E2 deletion mutants. Virus Res (2002) 0.75
Continuous monitoring of bovine spongiform encephalopathy rapid test performance by weak positive tissue controls and quality control charts. Vet Microbiol (2008) 0.75